Intrathecal medicines
30 results
Applied filters
Etoposide: informing intrathecal risk assessment
29 October 2025Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Rituximab: informing intrathecal risk assessment
29 October 2025Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Gentamicin: informing intrathecal risk assessment
29 October 2025Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Thiotepa: informing intrathecal risk assessment
29 October 2025Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Diamorphine hydrochloride: informing intrathecal risk assessment
29 October 2025Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Colistimethate sodium: informing intrathecal risk assessment
2 October 2025Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Vancomycin: informing intrathecal risk assessment
1 October 2025Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Cytarabine: informing intrathecal risk assessment
5 August 2025Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Amikacin: informing intrathecal risk assessment
5 August 2025Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Hydromorphone: informing intrathecal risk assessment
8 July 2025Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration